Impact of pre-transplant diffusion lung capacity for nitric oxide (DLNO) and of DLNO/pre-transplant diffusion lung capacity for carbon monoxide (DLNO/DLCO) ratio on pulmonary outcomes in adults receiving allogeneic stem cell transplantation for hematological diseases

A Le Bourgeois; F Malard; P Chevallier; G Urbistandoy; T Guillaume; J Delaunay; P Peterlin; P Lemarchand; P Germaud; M Mohty; P Moreau; A Chambellan

doi:10.1038/bmt.2015.284

Impact of pre-transplant diffusion lung capacity for nitric oxide (DLNO) and of DLNO/pre-transplant diffusion lung capacity for carbon monoxide (DLNO/DLCO) ratio on pulmonary outcomes in adults receiving allogeneic stem cell transplantation for hematological diseases

Bone Marrow Transplant. 2016 Apr;51(4):589-92. doi: 10.1038/bmt.2015.284. Epub 2015 Nov 23.

Authors

A Le Bourgeois¹, F Malard^{1

2

3

4}, P Chevallier¹, G Urbistandoy⁵, T Guillaume¹, J Delaunay¹, P Peterlin¹, P Lemarchand^{5

6

7

8}, P Germaud⁵, M Mohty^{1

3

4}, P Moreau¹, A Chambellan^{5

6

7

8}

Affiliations

¹ CHU de Nantes, Hématologie Clinique, Centre d'Investigation Clinique en Cancérologie (CI2C), Nantes, France.
² INSERM, UMR 1064-Center for Research in Transplantation and Immunology, Nantes, France.
³ Centre de recherche Saint-Antoine, INSERM, UMRs 938, Paris, France.
⁴ Université Pierre et Marie Curie, Paris, France.
⁵ INSERM, UMR1087, l'institut du thorax, Nantes, France.
⁶ CNRS, UMR 6291, Nantes, France.
⁷ Université de Nantes, Nantes, France.
⁸ CHU de Nantes, Nantes, France.

PMID: 26595083
DOI: 10.1038/bmt.2015.284

No abstract available

Publication types

Clinical Trial
Letter
Multicenter Study

MeSH terms

Adult
Aged
Allografts
Carbon Monoxide / metabolism*
Female
Hematologic Diseases* / metabolism
Hematologic Diseases* / mortality
Hematologic Diseases* / physiopathology
Hematologic Diseases* / therapy
Hematopoietic Stem Cell Transplantation*
Humans
Lung Volume Measurements
Male
Middle Aged
Nitric Oxide / metabolism*

Substances

Nitric Oxide
Carbon Monoxide